Biotech & Longevity · Thursday, 6 August 2026

01 · Briefing · what happened

The muscle pills that hid a hormone, and the invisible line every drug walks

Biotech & Longevity 2 min 7 sources

A US peptide company was jailed for selling unapproved muscle pills secretly laced with testosterone, pushing one buyer into psychosis. It is the loudest sign yet of a market that sells drugs with no dose you can trust.

5 yrs 10 mo

jail term

for the company owner

54,000

buyers named

in the case against the firm

167

victims come forward

some with blood clots, heart problems

18 mo

market boom

peptides and SARMs going mainstream

At a glance

A US peptide-company owner was jailed for five years and ten months for selling unapproved muscle pills.
The pills, sold as tested supplements, were secretly laced with testosterone; 54,000 buyers are named in the case.
One buyer sank into a two-year steroid-induced psychosis and recovered only when the pills ran out.
The FDA warned the firm from 2020 and seized products in 2023, but took six more months to close it.
The market for these unapproved drugs has boomed for 18 months as US rules loosen.
The same danger runs through medicine: a gene-therapy child died as doses were pushed higher.

Forces in play

Unregulated market High

peptides sold in a legal middle zone

Rules loosening Building

US panel opening the door wider

Enforcement Steady

years of warnings, one big conviction

Buyer awareness Easing

the conviction put the risk in the open

In play Paradigm Peptides — sold laced supplements, owner jailed Daniel Murphy — buyer driven into psychosis, since recovered The FDA — warned from 2020, closed the firm in 2024 RFK Jr's health panel — loosening restrictions on peptides

How it unfolded

2020 FDA starts warning the company
2023 FDA seizes products, finds testosterone
Dec 2024 Murphy runs out of pills and starts to recover
This week the owner is jailed for nearly six years

Full briefing

The owner of a US company that sold “muscle-building” supplements online was jailed this week for five years and ten months [1]. He had admitted deliberately selling unapproved drugs and faking the safety paperwork [1]. His sister got sixteen months [1]. The pills, marketed as tested “dietary supplements,” had been secretly mixed with testosterone [1].

One of the 54,000 buyers named in the case, Daniel Murphy, 32, thought he was taking a safe supplement to build muscle [1]. Over two years his mind unravelled into a full psychosis - he came to believe his wife was stealing his business and his mother-in-law wanted to kill him [1]. A psychiatrist testified it was a steroid-induced psychosis [1]. He recovered only after the pills ran out [1].

The company, Paradigm Peptides, had claimed it “stringently” tested every product for “purity and potency” [1]. It tested nothing, faked the certificates, and imported the pills from China and India [1]. The US drug regulator, the FDA, had been sending warning letters since 2020 and seized products in 2023, but took another six months to shut it down [1]. So far 167 victims have come forward; others suffered blood clots and heart problems [1].

Testosterone is a real medicine when a doctor prescribes and monitors it. Taken blind, at an unknown dose, it can cause “serious psychiatric effects,” liver damage, and heart problems [1]. That is the whole danger here: not a poison, but a real drug given without the one thing that makes it safe - a known dose.

The wider market. Peptides and SARMs are short protein chains and muscle-targeting compounds sold as “not for human consumption” [1]. They have exploded into the mainstream over the past 18 months, pushed by fitness influencers [1]. In the US, a health panel under Robert F. Kennedy Jr. is loosening restrictions, opening the way for a market of untested drugs sold through lightly regulated compounding pharmacies [2]. These products sit in a legal middle zone: legal to buy, not approved for humans, and outside the quality controls that fix a drug’s dose and purity [1].

Dosing past the marked line, elsewhere too. In China, a child in a CRISPR gene-editing trial for muscular dystrophy has died - the second such death [3]. It followed the company saying it was about to test a higher dose [3]. Gene therapies carry the tightest safety margin in medicine: too little does nothing, too much can be fatal. And in the US, Eli Lilly is widening “special access” to retatrutide, a powerful obesity drug not yet approved [4][5]. More patients can now take it before its safe dose is settled by trials [4]. Even approved drugs walk this line every day: the common painkiller tramadol carries a boxed warning that a dose increase can cause fatal breathing failure [6]. The rule holds even for vitamins - a large trial is testing whether a high dose of vitamin D helps bowel cancer, because more is not automatically better [7].

02 · Lesson · why it matters

The narrow band every drug has to land in

Every drug lives between a dose too small to work and one large enough to harm, and its safety is how wide that gap is.

How it works

Below a floor, a dose does nothing
Above a ceiling, the same drug harms
The gap between is the window you must land in
A narrow gap is easy to overshoot
Trials, labels and doctors exist to mark the window
Strip those away and you dose blind

The twist

A drug's danger is not the dose that harms you - it is how small the gap is between that and the dose that helps.

Where you've seen this

Anaesthesia

too little and you wake mid-surgery, too much and you never wake

Fertiliser

too little and nothing grows, too much and it burns the crop

Training load

too little and muscle never adapts, too much and it tears

Blood thinners

too little and you clot, too much and you bleed

The catch

The window is not fixed - it shifts with body weight, liver, genes and other drugs, so even a mapped dose is not safe for everyone.

Full lesson

Two lines, and the space between them

Every drug has two invisible lines. Below the first, the dose does nothing. Above the second, it starts to hurt you. The useful space is the gap in between - the band where the drug helps without harming.

Doctors call that gap the therapeutic window. It is the whole game. A medicine is only usable if the window is wide enough to hit reliably. Aspirin has a generous one; you would have to take a startling amount to get into trouble. Others have a window so tight that a slightly larger dose can tip a treatment into a poisoning.

Testosterone, the hormone hidden inside those muscle pills, has a real medical use. Prescribed and monitored, it sits inside its window. Taken blind, at an unknown amount, it drifts past the far line - and the harm arrives as psychiatric collapse, clot, or a failing heart.

The danger is the narrowness, not the poison

Here is the part that surprises people. The thing that makes a drug dangerous is not that a high dose harms you. Every substance harms you at a high enough dose - water included. What matters is the distance between the dose that helps and the dose that hurts.

A wide window forgives an imperfect dose. You can be a little off and still land in the band. A narrow window punishes the same small error. The gap between “working” and “harming” is so thin that an ordinary-looking dose can carry you across it.

This is why gene therapy is the sharpest case in medicine. Its window can be desperately tight. In the trial where a child died this week, the low dose seemed to do nothing, so the plan was to push higher. Somewhere past the near line lies the far one. The distance between “no effect” and “fatal” was too small to cross safely.

The window is invisible until someone draws it

Neither line is marked on the drug. You cannot see them, taste them, or feel them coming. This is the quiet fact underneath the whole apparatus of medicine.

The clinical trial exists to find the two lines. The label prints the safe dose between them. The pharmacist measures it out. The doctor watches for the signs that a particular body has a narrower window than the average. None of it is bureaucracy for its own sake. It is a map of a band you cannot otherwise see.

Daniel Murphy had no map. He did not know where his window was. He did not even know he was taking testosterone. So he could not connect two years of unravelling to the pills in his hand. He was walking across ground with no marked edges, in the dark.

Who is standing on that ground

It is easy to file this under “reckless gym-goers.” But the map is missing for a growing share of ordinary people. The peptide and SARM market has gone mainstream in eighteen months, sold by influencers as tested and safe. A powerful obesity drug is being handed out before its trials have finished settling the safe dose. Rules that draw the lines are being loosened, not tightened.

Each of those moves erases part of a map that most buyers never knew they were relying on. The people who take these products are not choosing to dose blind. They believe the window is drawn, because it always used to be. The label said “stringently tested.” It was tested by no one.

The whole you cannot see

The lesson is not that these drugs are evil, or that every buyer is a fool. It is that “safe” and “dangerous” were never fixed properties of a substance. They are questions about a gap - and about whether anyone has measured where its edges lie for you, today, in your body.

We move through a world full of these invisible bands, trusting that someone, somewhere, has marked the edges. Most of the time someone has, and we never notice the work. The unsettling part is how little any of us could tell, from the inside, on the day the marking stopped.

03 · Lab · your turn

Hit the window

Rehearse aiming a dose into the band between too-little and too-much, and feel why a narrow window is dangerous even when you aim right.

04 · Hope · carry this

For every invisible line a drug walks, someone spent years learning where it lies - and that patient work is what let this harm be caught and answered.